umu.sePublications
Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Phase I study of PKC412 (N-benzoyl-staurosporine), a novel oral protein kinase C inhibitor, combined with gemcitabine and cisplatin in patients with non-small-cell lung cancer
Umeå University, Faculty of Medicine, Radiation Sciences, Oncology.
Show others and affiliations
2004 (English)In: Ann Oncol, ISSN 0923-7534, Vol. 15, no 2, 316-323 p.Article in journal (Refereed) Published
Place, publisher, year, edition, pages
2004. Vol. 15, no 2, 316-323 p.
Keyword [en]
anti-angiogenesis, cell cycle inhibitor, protein kinase C
Identifiers
URN: urn:nbn:se:umu:diva-15510DOI: doi:10.1093/annonc/mdh052PubMedID: 14760128OAI: oai:DiVA.org:umu-15510DiVA: diva2:155182
Available from: 2007-02-26 Created: 2007-02-26 Last updated: 2011-01-12Bibliographically approved

Open Access in DiVA

No full text

Other links

Publisher's full textPubMed

Authority records BETA

Henriksson, Roger

Search in DiVA

By author/editor
Henriksson, Roger
By organisation
Oncology

Search outside of DiVA

GoogleGoogle Scholar

doi
pubmed
urn-nbn

Altmetric score

doi
pubmed
urn-nbn
Total: 24 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf